BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1357683)

  • 1. Use of bromocriptine to prevent puerperal lactation during neuroleptic treatment of chronic schizophrenia.
    Wolf R
    Pharmacopsychiatry; 1992 Sep; 25(5):240-2. PubMed ID: 1357683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug treatment of schizophrenic psychoses in puerperium].
    Olbrich HM; Martin P
    Nervenarzt; 1994 Jul; 65(7):482-5. PubMed ID: 7800093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of high single doses of bromocriptine in schizophrenic patients with elevated serum prolactin levels and extrapyramidal side effects associated with neuroleptic treatment (author's transl)].
    Ringwald E; Lustig A; Moscovici M; Spiegel R; Vamos E
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):318-24. PubMed ID: 6111093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Puerperal inhibition of lactation with metergoline or bromocriptine].
    Fischer T; Streitmatter A; Gerede A; Frauendorf A; Krause M; Feige A
    Z Geburtshilfe Neonatol; 1995; 199(3):111-5. PubMed ID: 7553254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use and value of the therapeutic neuroleptic-bromocriptine combination in schizophrenia].
    Lombertie ER; Durelle G; Fuseau A
    Ann Med Psychol (Paris); 1995 Oct; 153(8):531-4. PubMed ID: 8561400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine associated with symptom exacerbation during neuroleptic treatment of schizoaffective schizophrenia.
    Frye PE; Pariser SF; Kim MH; O'Shaughnessy RW
    J Clin Psychiatry; 1982 Jun; 43(6):252-3. PubMed ID: 7200978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
    Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
    J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma dopamine beta hydroxylase activity in chronic schizophrenic patients tested with single dose of 2-bromo-alpha ergocriptine (Parlodel).
    Vardi J; Flechter S; Oberman Z; Segal R; Shogan G; Haker O
    Encephale; 1981; 7(1):95-103. PubMed ID: 7227288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine in augmentation of antipsychotic response in chronic schizophrenia: a negative pilot report.
    Wells BG; Chu CC; Abi-Darghum A; Saini TS
    Pharmacopsychiatry; 1991 Jul; 24(4):118-20. PubMed ID: 1684441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bromocriptine therapy].
    König MP
    Schweiz Med Wochenschr; 1981 Feb; 111(9):303-8. PubMed ID: 6111843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial plasma prolactin levels in neuroleptic-induced galactorrhea: a case report.
    Gioia P; Asnis G
    J Clin Psychiatry; 1988 Jan; 49(1):29-31. PubMed ID: 2891689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of bromocriptine and chlorotrianisene in preventing postpartum lactation.
    Yuen BH; Pendleton HJ; Blair S
    Can Med Assoc J; 1977 Oct; 117(8):919-21. PubMed ID: 334356
    [No Abstract]   [Full Text] [Related]  

  • 13. Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics.
    Naber D; Ackenheil M; Laakman G; Fischer H; von Werder K
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):325-30. PubMed ID: 6111094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of the bromocriptine test in schizophrenia patients resistant to neuroleptic therapy].
    Ryzhakov BA; Nuller IU
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(3):79-80. PubMed ID: 1359722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic-refractory patients and their drug plasma levels.
    Berrios GE
    Encephale; 1982; 8(4):465-85. PubMed ID: 6129961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine in an injectable retard form for puerperal lactation suppression: comparison with Estandron prolongatum.
    Defoort P; Thiery M; Baele G; Clement D; Dhont M
    Obstet Gynecol; 1987 Dec; 70(6):866-9. PubMed ID: 3684122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The behavioral toxicity of bromocriptine in patients with psychiatric illness.
    Perovich RM; Lieberman JA; Fleischhacker WW; Alvir J
    J Clin Psychopharmacol; 1989 Dec; 9(6):417-22. PubMed ID: 2574194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of dopaminergic drugs (pyridoxine, 2-bromo-alpha-ergocriptine, piribedil) in blocking lactation].
    Lo Dico G; Milia S; Firinu C; Pes F; Masala A; Alagna S; Stoppelli I
    Minerva Ginecol; 1980 Sep; 32(9):771-9. PubMed ID: 7219829
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.